tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Pasha Sarraf, 3 are a HOLD (25%), 8 are a BUY (66.67%), 1 are a SELL (8.33%).
Analyst Pasha Sarraf, carries an average stock price target met ratio of 83.33% that have a potential upside of 73.17% achieved within 620 days. Previously, Pasha Sarraf worked at LEERINK.
Pasha Sarraf’s has documented 24 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACRS, Aclaris Therapeutics at 04-Mar-2021.
Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 3/4/2021. The price target of $26 was fulfilled within 15 days with a profit of $4.86 (22.99%) receiving and performance score of 15.33.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 23-Dec-2024
$16
$13.36 (506.06%)
2 months 22 days ago
(20-Oct-2025)
0/6 (0%)
$13.99 (696.02%)
Buy
Since 09-May-2025
8 months 2 days ago
(09-May-2025)
0/7 (0%)
$23.92 (169.89%)
Hold
Since 13-Nov-2023
$2
$-0.64 (-24.24%)
$2
10 months 15 days ago
(27-Feb-2025)
2/4 (50%)
$0.05 (2.56%)
271
Buy
Since 19-Nov-2024
$8
$5.36 (203.03%)
1 years 1 months 23 days ago
(19-Nov-2024)
0/3 (0%)
$3.41 (74.29%)
Buy
Since 19-Nov-2024
$7
$4.36 (165.15%)
1 years 1 months 23 days ago
(19-Nov-2024)
1/4 (25%)
$2.41 (52.51%)
315
What Year was the first public recommendation made by Pasha Sarraf?
